Evidence map›Paper›PMID 35372882›Full record

ArticleKidney3602020

The Characteristics, Dynamics, and the Risk of Death in COVID-19 Positive Dialysis Patients in London, UK.

Dalvir Kular, Irina Chis Ster, Alexander Sarnowski, Eirini Lioudaki, Dandisonba C B Braide-Azikiwe, Martin L Ford, David Makanjuola, Alexandra Rankin, Hugh Cairns, Joyce Popoola and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Kidney360, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Observational
  11. Observational
  12. Review
  13. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Dalvir KularRenal Unit, St Helier Hospital, Epsom and St Helier University Hospitals National Health Service Trust, Epsom, United Kingdom.ORCID 0000-0001-8489-7158
Irina Chis SterInstitute of Infection and Immunity, St George's University of London, London, United Kingdom.ORCID 0000-0003-2637-1259
Alexander SarnowskiRenal and Transplantation Unit, St George's University Hospital National Health Service Foundation Trust, London, United Kingdom.
Eirini LioudakiRenal Unit, King's College Hospital National Health Service Foundation Trust, London, United Kingdom.
Dandisonba C B Braide-AzikiweRenal Unit, King's College Hospital National Health Service Foundation Trust, London, United Kingdom.
Martin L FordRenal Unit, King's College Hospital National Health Service Foundation Trust, London, United Kingdom.
David MakanjuolaRenal Unit, St Helier Hospital, Epsom and St Helier University Hospitals National Health Service Trust, Epsom, United Kingdom.
Alexandra RankinRenal Unit, King's College Hospital National Health Service Foundation Trust, London, United Kingdom.
Hugh CairnsRenal Unit, King's College Hospital National Health Service Foundation Trust, London, United Kingdom.
Joyce PopoolaRenal and Transplantation Unit, St George's University Hospital National Health Service Foundation Trust, London, United Kingdom.
Nicholas ColeRenal Unit, St Helier Hospital, Epsom and St Helier University Hospitals National Health Service Trust, Epsom, United Kingdom.
Mysore PhanishRenal Unit, St Helier Hospital, Epsom and St Helier University Hospitals National Health Service Trust, Epsom, United Kingdom.
Richard HullRenal and Transplantation Unit, St George's University Hospital National Health Service Foundation Trust, London, United Kingdom.
Pauline A SwiftRenal Unit, St Helier Hospital, Epsom and St Helier University Hospitals National Health Service Trust, Epsom, United Kingdom.
Debasish BanerjeeRenal and Transplantation Unit, St George's University Hospital National Health Service Foundation Trust, London, United Kingdom.ORCID 0000-0002-6863-2325
National Health Service · GBSt George's, University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients on dialysis with frequent comorbidities, advanced age, and frailty, who visit treatment facilities frequently, are perhaps more prone to SARS-CoV-2 infection and related death-the risk factors and dynamics of which are unknown. The aim of this study was to investigate the hospital outcomes in patients on dialysis infected with SARS-CoV-2. Methods: Data on 224 patients on hemodialysis between February 29, 2020 and May 15, 2020 with confirmed SARS-CoV-2 were analyzed for outcomes and potential risk factors for death, using a competing risk-regression model assessed by subdistribution hazards ratio (SHR). Results: Crude data analyses suggest an overall case-fatality ratio of 23% (95% CI, 17% to 28%) overall, but that varies across age groups from 11% (95% CI, 0.9% to 9.2%) in patients ≤50 years old and 32% (95% CI, 17% to 48%) in patients >80 years; with 60% of deaths occurring in the first 15 days and 80% within 21 days, indicating a rapid deterioration toward death after admission. Almost 90% of surviving patients were discharged within 28 days. Death was more likely than hospital discharge in patients who were more frail (WHO performance status, 3-4; SHR, 2.16 [95% CI, 1.25 to 3.74]; Conclusions: This report discusses the outcomes of a large cohort of patients on dialysis. We found SARS-CoV-2 infection affected more patients with diabetes and those who were non-White, with a high case-fatality ratio, which increased significantly with age, frailty, smoking, increasing CRP, and neutrophil:lymphocyte ratio at presentation.

Indexed as

COVID-19Cohort StudiesHumansLondonMiddle AgedRenal DialysisSARS-CoV-2clinical nephrologyCOVID-19frailtyhemodialysisLondonmortalitymortality riskperitoneal dialysisUnited Kingdom

Identifiers

PMID35372882
PMCPMC8815514
OpenAlexW3086771273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.